ABVC BioPharma Inc
ABVC BioPharma Inc (ABVC) Implied Volatility Current
ABVC's 30 day implied volatility is 333.60%, with an IV Rank of 44.84%. This is an average IV Rank versus the past year, meaning ABVC BioPharma Inc options are fairly priced and currently offer no clear edge to buyers or sellers. ABVC's 30 day historical volatility sits at 55.80%, which means implied volatility is running 277.80 points above historical volatility, as of Nov 13, 2026.
Read more
Tracking ABVC implied volatility helps you spot when ABVC BioPharma Inc options are historically cheap or expensive, and where the best trades are hiding. When ABVC IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor ABVC implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking ABVC IV rank helps you see whether ABVC's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage.
Implied Volatility
IV is slightly elevated. Premiums are richer, leaning toward sellers.
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →